Showing results (2601-2610 of 2,835) with videos related to

Sort By:
Pageof 284
JCO Oncology Practice|January 23, 2024
Cost-Effectiveness of Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Older Patients With High-Risk Myelodysplastic Syndrome: Analysis of BMT CTN 1102Wael Saber, Aasthaa Bansal, Lily Li, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|September 1, 2020
Pathological nodal disease defines survival outcomes in patients with lung cancer with tumour major pathological response following neoadjuvant chemotherapyErin M Corsini, Annikka Weissferdt, Apar Pataer, et al.
The Annals of Thoracic Surgery|August 29, 2020
Modified En Bloc Esophagectomy Compared With Standard Resection After Neoadjuvant ChemoradiationErin M Corsini, Kyle G Mitchell, Nicolas Zhou, et al.
Antiviral Therapy|April 3, 2020
Differences in social and mental well-being of long-term survivors among people who inject drugs and other participants in the Swiss HIV Cohort Study: 1980-2018Katharina Kusejko, Alex Marzel, Huyen Nguyen, et al.
The Annals of Thoracic Surgery|May 10, 2021
Extrapleural Pneumonectomy Versus Pleurectomy/Decortication for Malignant Pleural MesotheliomaNicolas Zhou, David C Rice, Anne S Tsao, et al.
Oncogene|September 27, 2019
Therapeutic targeting of the PI4K2A/PKR lysosome network is critical for misfolded protein clearance and survival in cancer cellsApar Pataer, Bulent Ozpolat, RuPing Shao, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|December 7, 2017
Predictors of trimodality therapy and trends in therapy for malignant pleural mesotheliomaDavid B Nelson, David C Rice, Jiangong Niu, et al.
The British Journal of Surgery|June 7, 2021
Analysis of trimodal and bimodal therapy in a selective-surgery paradigm for locally advanced oesophageal squamous cell carcinomaN Zhou, K G Mitchell, E M Corsini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2015
Bevacizumab continuation versus no continuation after first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a randomized phase III non-inferiority trial (SAKK 41/06)D Koeberle, D C Betticher, R von Moos, et al.
Journal of Surgical Oncology|October 25, 2023
Do resected colorectal cancer patients need early chest imaging? Impact of clinicopathologic characteristics on time to development of pulmonary metastasesNathaniel Deboever, Erin M Bayley, Michael A Eisenberg, et al.
Pageof 284